BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tarr GAM, Oltean HN, Phipps AI, Rabinowitz P, Tarr PI. Case definitions of hemolytic uremic syndrome following Escherichia coli O157:H7 infection vary in validity. Int J Med Microbiol 2018;308:1121-7. [PMID: 30466555 DOI: 10.1016/j.ijmm.2018.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 McKee RS, Schnadower D, Tarr PI, Xie J, Finkelstein Y, Desai N, Lane RD, Bergmann KR, Kaplan RL, Hariharan S, Cruz AT, Cohen DM, Dixon A, Ramgopal S, Rominger A, Powell EC, Kilgar J, Michelson KA, Beer D, Bitzan M, Pruitt CM, Yen K, Meckler GD, Plint AC, Bradin S, Abramo TJ, Gouin S, Kam AJ, Schuh A, Balamuth F, Hunley TE, Kanegaye JT, Jones NE, Avva U, Porter R, Fein DM, Louie JP, Freedman SB; Pediatric Emergency Medicine Collaborative Research Committee and Pediatric Emergency Research Canada. Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children. Clin Infect Dis 2020;70:1643-51. [PMID: 31125419 DOI: 10.1093/cid/ciz432] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
2 Vachon MS, Khalid M, Tarr GAM, Hedberg C, Brown JA. Farm animal contact is associated with progression to Hemolytic uremic syndrome in patients with Shiga toxin-producing Escherichia coli - Indiana, 2012-2018. One Health 2020;11:100175. [PMID: 33392374 DOI: 10.1016/j.onehlt.2020.100175] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Tarr PI, Freedman SB. Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 2022;38:30-8. [PMID: 34871193 DOI: 10.1097/MOG.0000000000000798] [Reference Citation Analysis]